Family Care Hospitals Ltd Q3 FY26 – ₹0.06 Cr Revenue, ₹-0.96 Cr Loss, 61.7% Promoter Pledge & a Balance Sheet That Needs ICU
1. At a Glance – Blink and You’ll Miss the Revenue
Family Care Hospitals Ltd currently trades at ₹3.49, carrying a market cap of ~₹18.8 crore, which is roughly what a decent Mumbai diagnostic lab spends on interior design. Over the last 3 months, the stock is down ~19.6%, and over 1 year it’s down ~47.4%, which means long-term shareholders have experienced both emotional growth and spiritual detachment.
Latest quarterly numbers (Q3 FY26) show sales of just ₹0.06 crore and a PAT loss of ₹-0.96 crore. Yes, revenue is so small that Excel auto-rounds it. Despite this, Screener shows ROE at 85.5% and ROCE at 79.2%, which looks sexy until you realize this is largely because net worth is deeply negative, making ratios behave like drunk uncles at a wedding.
The company once talked about 150 beds, 30 specialties, 40 ICU beds, AI integration, and global ambitions. Today, it has shut down all hospital operations since October 2024, vacated its Mira Road premises, and is surviving on diagnostic and pharmacy tie-ups plus hope, warrants, and press releases.
Promoter holding stands at 18.54%, of which 61.7% is pledged. That’s not skin in the game; that’s skin in the pawnshop. Curious already? Good. Keep reading.
2. Introduction – From Hospital Chain to Case Study
Family Care Hospitals Ltd (FCHL), incorporated in 1994, was supposed to be a healthcare services company. Over the years, it tried to be many things: a hospital operator, a healthcare service provider, an AI-healthtech visionary, and lately, a corporate governance thriller.
At its peak narrative, FCHL claimed:
150 beds
30 specialties
300 allied staff
40 ICU beds
On paper, that sounds like a respectable mid-sized hospital. On the ground, by October 2024, all hospital operations were shut down after vacating the Mira Road premises. Since then, the company operates only limited diagnostic and pharmacy tie-ups, while still filing quarterly results like a listed company is supposed to.
What makes FCHL fascinating (and not in a good way) is the gap between ambition and execution. On one side, there’s talk of AI integration, global app launches, and ₹50 crore investment approvals. On the other side, there are court orders, attached movable properties, recurring losses, and erosion of net worth.
This is not a boring zombie company quietly fading away. This is a loud, press-release-friendly, warrant-issuing, management-reshuffling saga that keeps finding new ways to stay listed.
So the real question: Is this a turnaround story in deep distress, or just a listed shell with healthcare vocabulary? Let’s dissect.
3. Business Model – WTF Do They Even Do?
Historically, FCHL’s business model was simple:
Run hospitals → treat patients → earn money → repeat.
In theory.
What they claim to do:
Provide healthcare services
Integrate AI technology with traditional healthcare delivery
Develop healthcare software/apps with Ready Technologies, a unit of Onelife Capital Advisors Ltd (promoter group company)
Market these solutions in India and abroad
What they actually do right now:
No hospital operations since October 2024
Limited diagnostic and pharmacy tie-ups
Generate negligible operating revenue
Issue warrants, reshuffle management, and survive quarter to quarter
The much-talked-about “911 App”, planned for a new version launch in FY25, is positioned as a healthcare app. However, there is no disclosed revenue contribution, no user metrics, no monetization clarity, and no segment reporting that shows this app actually paying bills.
Revenue breakup for FY25:
Healthcare services: ~71%
Miscellaneous income: ~25%
Interest on FD & IT refund: ~4%
When “miscellaneous income” is one-fourth of revenue and hospitals are shut, you know the core engine is off and the generator is running on fumes.
If you had to explain FCHL to a lazy investor:
“It’s a healthcare company without hospitals, a tech company without tech revenue, and a finance company that keeps approving loans and investments while making losses.”
Sounds efficient, no?
4. Financials Overview – Numbers That Need Therapy
Result Type Lock
The latest official heading clearly states “Quarterly Results”. 👉 This is QUARTERLY RESULTS. EPS treatment is locked accordingly.
